Main contents starts here
Search Results
1 - 20 of about 418
Total 418 documents found.
- Investor Information Overview
- Investor information, IR News, Financial Results, Reports, Presentation, Event, IR Calendar
- Financial Highlights
- 5-year Summary of Selected Financial Data
- Quarterly Results FY2010 (April 2010-March 2011)
- Takeda’s quarterly earnings statements : Financial Statements, Data Book, Earnings Release Presentation
- Reports & Publications
- This page is a library which contains Takeda’s quarterly financial results, R&D activities, annual reports and booklets.
- Segment Information
- Segment Information of Takeda, such as sales by business segment, sales by geographical segment, overseas sales ratio and sales of major subsidiaries and affiliates.
- Sales of Major Products
- Summary of sales of major products of Takeda.
- Presentations & Events 2010
- Financial Results
- Quarterly Results FY2009 (April 2009-March 2010)
- Takeda’s quarterly earnings statements : Financial Statements, Data Book, Earnings Release Presentation
- Presentations & Events 2009
- Conference & Events,Financial Results
- Quarterly Results FY2008 (April 2008-March 2009)
- Takeda’s quarterly earnings statements : Financial Statements, Data Book, Earnings Release Presentation
- Presentations & Events 2008
- Conference & Events,Financial Results
- Notice of Upward Revision to First Half Year Consolidated Financial Forecasts for Fiscal Year Ending March 31, 2009 October 20, 2008
- Osaka, Japan, October 20, 2008 --- Takeda Pharmaceutical Company Limited ("Takeda") announced today upward revision to first half year consolidated financial forecasts for fiscal year ending March 31, 2009. Takeda did not provide an updated forecast for the full-year consolidated financial forecasts for fiscal year ending March 31, 2009, as such figures are currently being determined and will be announced on November 4, 2009, at the time of the announcement of first half year financial results.
- Quarterly Results FY2007 (April 2007-March 2008)
- Takeda’s quarterly earnings statements : Financial Statements, Data Book, Earnings Release Presentation
- Presentations & Events 2007
- Conference & Events,Financial Results
- Takeda to Acquire Paradigm Therapeutics March 12, 2007
- OSAKA, JAPAN and CAMBRIDGE UK March 12, 2007 --- Takeda Pharmaceutical Company Limited ("Takeda") today announced that Takeda and Paradigm Therapeutics Limited ("Paradigm") agreed on March 12, 2007 to the acquisition of Paradigm by Takeda. Paradigm shareholders were advised by Avlar BioVentures Limited. Financial terms were not disclosed. Subject to completion, which is expected to occur within a few weeks, Paradigm will become a subsidiary of Takeda Europe Holdings B.V., a wholly owned subsidiary of Takeda. Additionally, Paradigm will be renamed Takeda Cambridge Limited, and Paradigm's subsidiary in Singapore will be renamed Takeda Singapore Pte Limited.
- Quarterly Results FY2006 (April 2006-March 2007)
- Takeda’s quarterly earnings statements : Financial Statements, Data Book, Earnings Release Presentation
- Presentations & Events 2006
- Conference & Events,Financial Results
- Quarterly Results FY2005 (April 2005-March 2006)
- Takeda’s quarterly earnings statements : Financial Statements, Data Book, Earnings Release Presentation
- Presentations & Events 2005
- Conference & Events,Financial Results
- TAP LICENSES PREVACID® INTELLECTUAL PROPERTY RIGHTS TO NOVARTIS FOR OTC DEVELOPMENT AND FUTURE COMMERCIALIZATION
− Agreement Part of TAP's Strategy to Maintain Its Leadershipin Area of Gastroenterological Products − December 21, 2005 - LAKE FOREST, Ill., Dec. 20, 2005 − TAP Pharmaceutical Products Inc. announced today that it has agreed to license its Prevacid® (lansoprazole) trademark and certain other intellectual property to Novartis for development and future commercialization in the over-the-counter (OTC) market. The agreement covers the United States and its territories. Financial terms were not disclosed.